PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 16, 2025European PsychiatryOpen Access

Genetic Considerations in Psychiatric Treatment for Individuals with Intellectual and Developmental Disabilities (IDD)

View Full Paper
Ask AI
Bookmark
Share

Authors

DVDaniela ValleHNHai M. NguyenBCBruce R. Carr

Discussion

Loading...

Member takes

Overview

Literature review shows genetic factors impact psychiatric care in individuals with IDD, suggesting tailored therapies.

Key Points

  • Genetic testing improves psychiatric treatment outcomes in individuals with IDD by guiding medication selection.
  • Fragile X syndrome commonly leads to ADHD and anxiety, influencing the choice of non-stimulant medications.
  • Pharmacogenetic insights enhance personalized treatment, minimizing side effects in IDD populations.
  • Identifying genetic variants like CYP2D6 can optimize drug metabolism and establish better therapeutic responses.

Cite This Study

Valle et al. (2025) studied this question.

synapsesocial.com/papers/68d4507331b076d99fa57bf1https://doi.org/10.1192/j.eurpsy.2025.1555
View Full Paper
Ask AI
Bookmark
Share